{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:17:45Z","timestamp":1778573865388,"version":"3.51.4"},"publisher-location":"Cham","reference-count":21,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032177742","type":"print"},{"value":"9783032177759","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-17775-9_4","type":"book-chapter","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T12:13:18Z","timestamp":1771157598000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes"],"prefix":"10.1007","author":[{"given":"Joakim","family":"Dillner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Smith SB, Temin S et al (2018) Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ 363:k4823. https:\/\/doi.org\/10.1136\/bmj.k4823","journal-title":"BMJ"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1038\/s41467-024-47909-x","volume":"15","author":"LS Arroyo M\u00fchr","year":"2024","unstructured":"Arroyo M\u00fchr LS, Gini A, Yilmaz E et al (2024) Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer. Nat Commun 15:3679. https:\/\/doi.org\/10.1038\/s41467-024-47909-x","journal-title":"Nat Commun"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ijc.35142","volume":"156","author":"LS Arroyo M\u00fchr","year":"2025","unstructured":"Arroyo M\u00fchr LS, Wang J, Hassan SS et al (2025) Nationwide registry-based trial of risk-stratified cervical screening. Int J Cancer 156:379\u2013388. https:\/\/doi.org\/10.1002\/ijc.35142","journal-title":"Int J Cancer"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","volume":"385","author":"V Bouvard","year":"2021","unstructured":"Bouvard V, Wentzensen N, Mackie A et al (2021) The IARC perspective on cervical cancer screening. N Engl J Med 385:1908\u20131918. https:\/\/doi.org\/10.1056\/NEJMsr2030640","journal-title":"N Engl J Med"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ijc.25649","volume":"129","author":"L Dillner","year":"2011","unstructured":"Dillner L, Kemetli L, Elfgren K et al (2011) Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities. Int J Cancer 129:151\u2013159. https:\/\/doi.org\/10.1002\/ijc.25649","journal-title":"Int J Cancer"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ejca.2015.03.008","volume":"51","author":"KM Elfstr\u00f6m","year":"2015","unstructured":"Elfstr\u00f6m KM, Arnheim-Dahlstr\u00f6m L, von Karsa L et al (2015) Cervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer 51:950\u2013968. https:\/\/doi.org\/10.1016\/j.ejca.2015.03.008","journal-title":"Eur J Cancer"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1002\/ijc.32374","volume":"145","author":"KM Elfstr\u00f6m","year":"2019","unstructured":"Elfstr\u00f6m KM, Sundstr\u00f6m K, Andersson S (2019) Increasing participation in cervical screening by targeting long-term nonattenders: randomized health services study. Int J Cancer 145:3033\u20133039. https:\/\/doi.org\/10.1002\/ijc.32374","journal-title":"Int J Cancer"},{"key":"4_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80905","volume":"12","author":"M Elfstr\u00f6m","year":"2023","unstructured":"Elfstr\u00f6m M, Gray PG, Dillner J (2023) Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic. elife 12:e80905. https:\/\/doi.org\/10.7554\/eLife.80905","journal-title":"elife"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1093\/infdis\/jiaf032","volume":"231","author":"P Gray","year":"2025","unstructured":"Gray P, Wang J, Nordqvist Kleppe S et al (2025) Population-based age-period-cohort analysis of declining human papillomavirus prevalence. J Infect Dis 231:e638\u2013e649. https:\/\/doi.org\/10.1093\/infdis\/jiaf032","journal-title":"J Infect Dis"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ijc.33519","volume":"149","author":"M Hortlund","year":"2021","unstructured":"Hortlund M, van Mol T, Van de Pol F et al (2021) Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer. Int J Cancer 149:684\u2013691. https:\/\/doi.org\/10.1002\/ijc.33519","journal-title":"Int J Cancer"},{"key":"4_CR11","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"IARC","year":"2012","unstructured":"IARC (2012) IARC monographs on the evaluation of carcinogenic risks to humans, vol 100B. Biological Agents. IARC. Available at: https:\/\/publications.iarc.fr\/119. Accessed 29 June 2025"},{"key":"4_CR12","volume-title":"Cervical cancer screening: IARC handbooks of cancer prevention","author":"IARC","year":"2022","unstructured":"IARC (2022) Cervical cancer screening: IARC handbooks of cancer prevention, vol 18. IARC. Available from: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Handbooks-Of-Cancer-Prevention\/Cervical-Cancer-Screening-2022. Accessed 30 June 2025"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1080\/13696998.2022.2082777","volume":"25","author":"F Inturrisi","year":"2022","unstructured":"Inturrisi F, Berkhof J (2022) Pricing of HPV tests in Italian tender-based settings. J Med Econ 25:762\u2013768. https:\/\/doi.org\/10.1080\/13696998.2022.2082777","journal-title":"J Med Econ"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/ijc.32848","volume":"146","author":"H Kann","year":"2020","unstructured":"Kann H, Hortlund M, Eklund C et al (2020) Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: population-based nested case-control study. Int J Cancer 146:2539\u20132546. https:\/\/doi.org\/10.1002\/ijc.32848","journal-title":"Int J Cancer"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/infdis\/jiaa587","volume":"223","author":"K Sundstr\u00f6m","year":"2021","unstructured":"Sundstr\u00f6m K, Dillner J (2021) How many human papillomavirus types do we need to screen for? J Infect Dis 223:1510\u20131511. https:\/\/doi.org\/10.1093\/infdis\/jiaa587","journal-title":"J Infect Dis"},{"key":"4_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004304","volume":"20","author":"J Wang","year":"2023","unstructured":"Wang J, Elfstr\u00f6m KM, Lagheden C et al (2023) Impact of cervical screening by human papillomavirus genotype: population-based estimations. PLoS Med 20:e1004304. https:\/\/doi.org\/10.1371\/journal.pmed.1004304","journal-title":"PLoS Med"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"e886","DOI":"10.1016\/S2468-2667(24)00218-4","volume":"9","author":"J Wang","year":"2024","unstructured":"Wang J, Elfstr\u00f6m KM, Dillner J (2024a) Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden. Lancet Public Health 9:e886\u2013e895. https:\/\/doi.org\/10.1016\/S2468-2667(24)00218-4","journal-title":"Lancet Public Health"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ijc.34723","volume":"154","author":"J Wang","year":"2024","unstructured":"Wang J, Edvardsson H, Strander B et al (2024b) Long-term follow-up of cervical cancer incidence after normal cytological findings. Int J Cancer 154:448\u2013453. https:\/\/doi.org\/10.1002\/ijc.34723","journal-title":"Int J Cancer"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I et al (2024) Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 404:435\u2013444. https:\/\/doi.org\/10.1016\/S0140-6736(24)01097-3","journal-title":"Lancet"},{"key":"4_CR20","unstructured":"World Health Organization (2014) Comprehensive cervical cancer control: a guide to essential practice, 2nd edn. World Health Organization. Available at: https:\/\/iris.who.int\/handle\/10665\/144785. Accessed 27 June 2025"},{"key":"4_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105581","volume":"167","author":"E Yilmaz","year":"2023","unstructured":"Yilmaz E, Eklund C, Lagheden C (2023) First international proficiency study on human papillomavirus testing in cervical cancer screening. J Clin Virol 167:105581. https:\/\/doi.org\/10.1016\/j.jcv.2023.105581","journal-title":"J Clin Virol"}],"container-title":["Current Topics in Microbiology and Immunology","Human Papillomavirus Epidemiology, Immunology and Cervical Cancer Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-17775-9_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:06:21Z","timestamp":1778573181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-17775-9_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032177742","9783032177759"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-17775-9_4","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"16 February 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This chapter is a review of previously published accounts, and as such, no animal or human studies were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}